What Would You Do?
The Latest News
Thirty-Day Data From Low-Risk TAVR Trial Published and Presented
February 24, 2020—Online in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions, Ron Waksman, MD, et al published findings from a study of transcatheter aortic valve replacement (TAVR) in low-risk patients with symptomatic severe bicuspid aortic valve stenosis.
FDA Approves Early Feasibility Study and Grants Breakthrough Device Designation for Cardiovalve System
February 20, 2020—Cardiovalve announced that it has received FDA approval for an early feasibility study (EFS) of its transcatheter tricuspid valve replacement system for a tricuspid regurgitation (TR) indication.
Six-Month Data Published From Ablative Solutions’ Peregrine Postmarket Study
February 20, 2020—Ablative Solutions, Inc. announced that 6-month results from the Peregrine postmarket study were published by Professor Felix Mahfoud, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2020;13:471–484).
Pooled Analysis Supports Diagnostic Performance of CathWorks' Angiogram-Derived Fractional Flow Reserve
February 17, 2020—A pooled analysis of five prospective cohort studies sought to assess the diagnostic performance of FFRangio (CathWorks), an angiogram-derived fractional flow reserve (FFR) technology.
SCAI Multisociety Position Statement Addresses Occupational Health Hazards in Catheterization Labs
February 11, 2020—The Society for Cardiovascular Angiography & Interventions (SCAI) multisociety position statement on occupational health hazards of the catheterization laboratory has been published by Lloyd W. Klein, MD, et al online in SCAI’s Catheterization & Cardiovascular Interventions.
Philips’ DEFINE GPS Trial Will Assess Outcomes of PCI Guided by an Integrated Platform of iFR and Angiogram
February 11, 2020—Royal Philips announced a new randomized controlled trial to assess patient outcomes after receiving percutaneous coronary intervention (PCI) guided by Philips’ coregistration platform (which combines data of instant wave-free ratio (iFR) measurement and angiography) compared with the standard of care treatment guided by angiography alone.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.
TAVR Trials Guide
A summary of the study data for all of the TAVR devices available in the United States market.
Most Read Articles
Go Implant-Free in De Novo Lesions: DCB-Only Strategy
Limitations in Identifying and Managing HBR Patients Undergoing PCI